Skip to content
Disclosery

UBS Group AG: DRMA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of UBS Group AG on DRMA, newest first. How the timeline and the estimate are built.

UBS Group AG held 16,796 DRMA shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 16,796 shares
    Change vs previous 13F -18,812 shares

    <0.01% of the 13F portfolio, value $21,667.

    13F-HR 0001610520-26-000103 filed by UBS Group AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 35,608 shares
    Change vs previous 13F +34,371 shares

    <0.01% of the 13F portfolio, value $43,085.

    13F-HR 0001610520-26-000057 filed by UBS Group AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,237 shares
    Change vs previous 13F -8,810 shares

    <0.01% of the 13F portfolio, value $2,870.

    13F-HR 0001610520-26-000004 filed by UBS Group AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 10,047 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $50,436.

    13F-HR 0001193125-25-279802 filed by UBS Group AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).